What is PTHS's market capitalization?

PTHS (PTHS) reported market capitalization of $70.5M in Q1 2026.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

PTHS PTHS Market capitalization

Market capitalization at other companies

Cumberland PharmaceuticalsCPIX

$48.61M-17.7%

Journey Medical CorporationDERM

$128.18M-6.0%

Opko HealthOPK

$865.34M-22.4%

Zevra Therapeutics, Inc.ZVRA

$547.19M+35.0%

Theravance BiopharmaTBPH

$835.73M+89.2%

HRO

HarrowHROW

$1.31B+38.4%

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Computed from the period-end share price: $70.5M.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's market capitalization?: PTHS (PTHS) reported market capitalization of $70.5M in Q1 2026.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.